INBX•benzinga•
Inhibrx Biosciences Announces Departure Of Dr. Brendan Eckelman, Co-founder And Chief Scientific Officer And Appoints Dr. Carlos Bais And David Matly to CSO and President, Respectively
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on April 1, 2025 by benzinga